Guangbing Li

1. Zhang, L., et al., Inhibition of wild-type p53-induced phosphatase 1 promotes liver regeneration in mice by direct activation of mammalian target of rapamycin. Hepatology, 2015. 61(6): p. 2030-41. 2. Miao, R., et al., Identification of prognostic biomarkers in hepatitis B virus-related hepatocellular carcinoma and stratification by integrative multi-omics analysis. J Hepatol, 2014. 61(4): p. 840-9. 3. Li, G.B., et al., Protein phosphatase magnesium-dependent 1delta (PPM1D) mRNA expression is a prognosis marker for hepatocellular carcinoma. PLoS One, 2013. 8(3): p. e60775. 4. Li, G., et al., Upregulation of Leucine Zipper Protein mRNA in Hepatocellular Carcinoma Associated With Poor Prognosis. Technol Cancer Res Treat, 2016. 15(3): p. 517-22. 5. Li, G., et al., Long noncoding RNA plays a key role in metastasis and prognosis of hepatocellular carcinoma. Biomed Res Int, 2014. 2014: p. 780521. 6. Liu, C., et al., A novel PTEN gene promoter mutation and untypical Cowden syndrome. Chin J Cancer Res, 2013. 25(3): p. 306-11. 7. Liu, J., et al., FH535 inhibits the proliferation of HepG2 cells via downregulation of the Wnt/beta-catenin signaling pathway. Mol Med Rep, 2014. 9(4): p. 1289-92. 8. Li, G., et al., A Modified Suture Technique in Hepaticojejunostomy. Med Sci Monit, 2020. 26: p. e921896.